These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 39080094

  • 41. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
    Silverberg JI, Chiesa Fuxench ZC, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY.
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
    [Abstract] [Full Text] [Related]

  • 42. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K, Teixeira HD, de Bruin-Weller M, Bieber T, Soong W, Kabashima K, Werfel T, Zeng J, Huang X, Hu X, Hendrickson BA, Ladizinski B, Chu AD, Silverberg JI.
    Lancet; 2021 Jun 05; 397(10290):2169-2181. PubMed ID: 34023009
    [Abstract] [Full Text] [Related]

  • 43. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.
    de Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S, Girolomoni G, Papp K, Pink AE, Saba G, Werfel T, Eckert L.
    J Eur Acad Dermatol Venereol; 2020 May 05; 34(5):1026-1036. PubMed ID: 31587373
    [Abstract] [Full Text] [Related]

  • 44. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
    Silverberg JI, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Ong PY, Fuxench ZC, Simpson EL.
    Br J Dermatol; 2020 Jan 05; 182(1):104-111. PubMed ID: 30972740
    [Abstract] [Full Text] [Related]

  • 45. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
    Yosipovitch G, Gooderham MJ, Ständer S, Fonacier L, Szepietowski JC, Deleuran M, Girolomoni G, Su JC, Bushmakin AG, Cappelleri JC, Feeney C, Chan G, Thorpe AJ, Valdez H, Biswas P, Rojo R, DiBonaventura M, Myers DE.
    Am J Clin Dermatol; 2024 Jan 05; 25(1):127-138. PubMed ID: 37624488
    [Abstract] [Full Text] [Related]

  • 46. The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients.
    Salfi F, Amicucci G, Ferrara M, Tempesta D, De Berardinis A, Chiricozzi A, Peris K, Fargnoli MC, Esposito M.
    Arch Dermatol Res; 2023 Aug 05; 315(6):1577-1582. PubMed ID: 36749389
    [Abstract] [Full Text] [Related]

  • 47. Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults.
    Silverberg JI, Chiesa-Fuxench Z, Margolis D, Boguniewicz M, Fonacier L, Grayson M, Simpson E, Ong P.
    Dermatitis; 2023 Aug 05; 33(6S):S104-S113. PubMed ID: 33675326
    [Abstract] [Full Text] [Related]

  • 48. Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study.
    Paller AS, Siegfried EC, Simpson EL, Cork MJ, Sidbury R, Chen IH, Khokhar FA, Xiao J, Dubost-Brama A, Bansal A.
    Am J Clin Dermatol; 2024 Jul 05; 25(4):655-668. PubMed ID: 38743155
    [Abstract] [Full Text] [Related]

  • 49. Prevalence and Related Factors of Attention Deficit Hyperactivity Disorder in School-age Children With Atopic Dermatitis.
    Yu H, Zhang W.
    Altern Ther Health Med; 2024 Jan 05; 30(1):13-17. PubMed ID: 37773667
    [Abstract] [Full Text] [Related]

  • 50. Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.
    Huet F, Faffa MS, Poizeau F, Merhand S, Misery L, Brenaut E.
    Acta Derm Venereol; 2019 Mar 01; 99(3):279-283. PubMed ID: 30264161
    [Abstract] [Full Text] [Related]

  • 51. Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
    Thyssen JP, Bewley A, Ständer S, Castro C, Misery L, Kim BS, Biswas P, Chan G, Myers DE, Watkins M, Alderfer J, Güler E, Silverberg JI.
    Dermatology; 2024 Mar 01; 240(2):243-253. PubMed ID: 38081155
    [Abstract] [Full Text] [Related]

  • 52. Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients.
    Torisu-Itakura H, Anderson P, Piercy J, Pike J, Sakamoto A, Kabashima K.
    Curr Med Res Opin; 2022 Aug 01; 38(8):1401-1410. PubMed ID: 35787197
    [Abstract] [Full Text] [Related]

  • 53. Burden of atopic dermatitis in paediatric patients: an international cross-sectional study.
    Weidinger S, Simpson EL, Silverberg JI, Barbarot S, Eckert L, Mina-Osorio P, Rossi AB, Brignoli L, Mnif T, Guillemin I, Fenton MC, Delevry D, Chuang CC, Pellan M, Gadkari A.
    Br J Dermatol; 2024 May 17; 190(6):846-857. PubMed ID: 38048385
    [Abstract] [Full Text] [Related]

  • 54. Burden of skin pain in atopic dermatitis.
    Vakharia PP, Chopra R, Sacotte R, Patel KR, Singam V, Patel N, Immaneni S, White T, Kantor R, Hsu DY, Silverberg JI.
    Ann Allergy Asthma Immunol; 2017 Dec 17; 119(6):548-552.e3. PubMed ID: 29223299
    [Abstract] [Full Text] [Related]

  • 55. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H, Sciberras E, Mensah F, Gerner B, Efron D, Khano S, Oberklaid F.
    BMJ; 2015 Jan 20; 350():h68. PubMed ID: 25646809
    [Abstract] [Full Text] [Related]

  • 56. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.
    Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, Beck LA, Guttman-Yassky E, Pariser D, Blauvelt A, Weisman J, Lockshin B, Hultsch T, Zhang Q, Kamal MA, Davis JD, Akinlade B, Staudinger H, Hamilton JD, Graham NMH, Pirozzi G, Gadkari A, Eckert L, Stahl N, Yancopoulos GD, Ruddy M, Bansal A.
    JAMA Dermatol; 2020 Jan 01; 156(1):44-56. PubMed ID: 31693077
    [Abstract] [Full Text] [Related]

  • 57. Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
    Reich K, Silverberg JI, Papp KA, Deleuran M, Katoh N, Strober B, Beck LA, de Bruin-Weller M, Werfel T, Zhang F, Biswas P, DiBonaventura MD, Chan G, Johnson S, Farooqui SA, Kerkmann U, Clibborn C.
    J Eur Acad Dermatol Venereol; 2023 Oct 01; 37(10):2056-2066. PubMed ID: 37335885
    [Abstract] [Full Text] [Related]

  • 58. Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial.
    Eichenfield LF, Flohr C, Sidbury R, Siegfried E, Szalai Z, Galus R, Yao Z, Takahashi H, Barbarot S, Feeney C, Zhang F, DiBonaventura M, Rojo R, Valdez H, Chan G.
    JAMA Dermatol; 2021 Oct 01; 157(10):1165-1173. PubMed ID: 34406366
    [Abstract] [Full Text] [Related]

  • 59. Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
    Silverberg JI, Simpson EL, Wollenberg A, Bissonnette R, Kabashima K, DeLozier AM, Sun L, Cardillo T, Nunes FP, Reich K.
    JAMA Dermatol; 2021 Jun 01; 157(6):691-699. PubMed ID: 33978711
    [Abstract] [Full Text] [Related]

  • 60. Increased attention-deficit/hyperactivity symptoms in atopic dermatitis are associated with history of antihistamine use.
    Schmitt J, Buske-Kirschbaum A, Tesch F, Trikojat K, Stephan V, Abraham S, Bauer A, Nemat K, Plessow F, Roessner V.
    Allergy; 2018 Mar 01; 73(3):615-626. PubMed ID: 28975640
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.